As we step into 2026, we’re proud to continue supporting our clients with local UK expertise delivered at an international scale.
At Pharmidex, we support programmes from discovery through to IND-enabling studies, helping teams progress confidently from concept to clinic. With integrated in vivo, bioanalysis and translational capabilities, everything is delivered under one roof in the UK, ensuring quality, continuity and efficiency at every stage.
2025 was one of the most challenging years our industry has faced, yet together we continued to deliver meaningful science, supporting nearly 1,000 projects and contributing to medicines that make a real difference to patients’ lives.
Thank you to our clients and partners for your continued trust.
We look forward to supporting innovation and high-quality science in the year ahead.







